Reservoir and Phylogenetic Signatures Identify Distinct Subsets of HIV-1 Nonsuppressible Viremia
Adams, T.; Kang, C. K.; Mohammadi, A.; Mesquita, F.; Cohen, S.; Deligiannidis, E. A.; Edelstein, G. E.; Dorazio, D.; Kim, J.; de Andraca Serrano, A.; Moeser, M.; Hastings, L. E.; Carvalho, L.; Jordan, H.; Worrall, D. R.; Castillo-Mancilla, J. R.; Jilg, N.; Jacobson, J. M.; Tsibris, A. N.; Deeks, S.; Fletcher, C.; Llibre, J. M.; Anderson, P. L.; Zhou, S.; Joseph, S. B.; Sieg, S.; Yukl, S.; Etemad, B.; Li, J. Z.
Show abstract
In nonsuppressible HIV viremia (NSV), individuals have persistently detectable viral load despite adherence to [≥]2 fully active antiretroviral drugs. NSV represents an area of clinical uncertainty and an opportunity to understand the mechanisms of HIV persistence. We performed in-depth virologic characterization to identify distinct NSV phenotypes. We categorized participants into those who had persistent viremia after antiretroviral therapy (ART) initiation (primary NSV) and those who had NSV after a period of virologic suppression (secondary NSV). Despite the prolonged viremia, there was no significant evidence of active viral evolution in either the primary or secondary NSV groups. Primary NSV participants had >10-fold higher levels of intact proviral DNA by the intact proviral DNA assay (P<0.01). While the plasma of secondary NSV participants was dominated by a few large HIV clones, primary NSV participants had far more diverse plasma quasispecies with few clones (P<0.01). Primary NSV participants were also found to harbor distinct deletions within vif-vpr and had T-tropic virus. Transcriptional profiling of intracellular HIV RNA also suggested higher viral transcriptional activity in primary than in secondary NSV. In contrast, profiling of soluble inflammatory markers demonstrated largely comparable systemic inflammatory signatures across NSV subtypes. NSV is comprised of two distinct subsets of individuals, including a novel group with primary NSV characterized by prolonged viremia after ART initiation, an exceptionally large intact reservoir and highly diverse plasma virus populations arising from transcriptionally active proviral reservoirs, without evidence of ongoing evolution. These findings have implications for understanding mechanisms of HIV reservoir persistence on ART. One Sentence SummaryTwo distinct subsets of HIV-1 nonsuppressible viremia, primary and secondary, are identified and characterized by reservoir and phylogenetic characteristics.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Blockade of TGF-β signaling reactivates HIV-1/SIV reservoirs and immune responses in vivo 96%
- Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses 94%
- T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity 93%
Similar papers in this journal
- Proviruses in CD4+ T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia 95%
- The Replication-Competent HIV-1 Latent Reservoir is Primarily Established Near the Time of Therapy Initiation 94%
- Heightened resistance to type 1 interferons characterizes HIV-1 at transmission and following analytical treatment interruption 94%
Similar papers in this journal
- Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing 98%
- HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA 97%
- A near-full-length HIV-1 genome from 1966 recovered from formalin-fixed paraffin-embedded tissue 96%
Similar papers in this journal
Similar papers in this journal
- Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy 98%
- Differences in HIV-1 reservoir size, landscape characteristics and decay dynamics in acute and chronic treated HIV-1 Clade C infection 96%
- Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels as compared with therapy based on protease inhibitors 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.